Home / Advanced Search

  • Title/Keywords

  • Author/Affliations

  • Journal

  • Article Type

  • Start Year

  • End Year

Update SearchingClear
  • Articles
  • Online
Search Results (123)
  • Open Access

    ARTICLE

    Coordinated circRNA/lncRNA-Mediated Post-Transcriptional Regulation Balances Anthocyanin and cis-Zeatin Metabolism in Lycium ruthenicum

    Yiming Chen1,2, Qiong Luo1,*

    Phyton-International Journal of Experimental Botany, Vol.95, No.3, 2026, DOI:10.32604/phyton.2026.077896 - 31 March 2026

    Abstract Lycium ruthenicum Murray (black goji berry) is an economically important crop rich in anthocyanins, however, the post-transcriptional regulatory mechanisms underlying anthocyanin accumulation in its fruits are unknown. Here, we used whole-transcriptome sequencing to identify differentially expressed circRNAs and lncRNAs in black goji (BS4) and white goji (WS4). Furthermore, we analyzed the regulatory networks of the key ncRNAs and their target genes by combining targeted phytohormone metabolomics with molecular docking technology. We found that the circRNA plantcirc_001165 synergistically upregulated the flavonoid biosynthesis gene LrHCT with the lncRNA MSTRG.28703 to promote anthocyanin accumulation. However, MSTRG.28703 repressed LrZOX1 expression, leading More >

  • Open Access

    ARTICLE

    Integrated WGCNA and Experimental Validation Reveals LINC00595 as Necroptosis-Regulating lncRNAs in Prostate Cancer

    Kai Tang1, Shengxing Lu1, Cuie He2, Ruozeng Rong1,*

    BIOCELL, Vol.50, No.3, 2026, DOI:10.32604/biocell.2026.072154 - 23 March 2026

    Abstract Objectives: Prostate cancer (PCa) is a highly prevalent male malignancy with limited efficacy in advanced stages. Dysregulated modulation of necroptosis was reported to be tightly correlated with PCa initiation and progression. Herein, we aimed to identify necroptosis-associated long non-coding RNAs (lncRNAs) and delineate their functional roles in PCa through an integrated approach combining bioinformatic analyses and in vitro experimental validation. Methods: RNA sequencing data and corresponding clinical information of PCa were downloaded from The Cancer Genome Atlas (TCGA). Differentially expressed necroptosis-related genes (NRGs) and lncRNAs were screened, and necroptosis activity was assessed by single-sample gene set… More >

  • Open Access

    RETRACTION

    Retraction: Long Noncoding RNA (lncRNA) HOTAIR Affects Tumorigenesis and Metastasis of Non-Small Cell Lung Cancer by Upregulating miR-613

    Oncology Research Editorial Office

    Oncology Research, Vol.34, No.3, 2026, DOI:10.32604/or.2026.080056 - 24 February 2026

    Abstract This article has no abstract. More >

  • Open Access

    ARTICLE

    LncRNA FOXD2-AS1 Promotes Early Osteogenic Differentiation of H-BMSCs by Activating the JAK2/STAT3 Signaling Pathway

    Lihua Wang1, Zhimin Zhang1,*, Tao Wang2,*

    BIOCELL, Vol.50, No.2, 2026, DOI:10.32604/biocell.2025.074782 - 14 February 2026

    Abstract Objectives: The discovery of novel molecular targets to enhance the osteogenesis of human bone marrow-derived mesenchymal stem cells (H-BMSCs) represents a promising strategy for preventing and treating osteoporosis. Thus, the primary objective of this study is to elucidate the mechanisms by which long non-coding RNA FOXD2-AS1 (lncRNA FOXD2-AS1) regulates early osteogenic differentiation in H-BMSCs, thereby identifying potential therapeutic targets. Methods: Lentivirus-mediated vectors were constructed to either overexpress or silence FOXD2-AS1 in H-BMSCs. The effects of FOXD2-AS1 on osteogenesis were subsequently assessed by analyzing osteogenic marker expression and alkaline phosphatase (ALP) staining. To clarify the role… More >

  • Open Access

    REVIEW

    How Do LncRNAs Talk to miRNAs? Decoding Their Dialogue in Atherosclerosis

    Yating Wei1, Hongkang Yao1, Xian Shi2, Hong Chen3, Rongzong Ye4,*, Chaoqian Li1,*

    BIOCELL, Vol.50, No.2, 2026, DOI:10.32604/biocell.2025.072780 - 14 February 2026

    Abstract Atherosclerosis, characterized by the formation of fibrofatty lesions in the arterial wall, remains a leading cause of global morbidity and mortality. Emerging evidence highlights the critical regulatory roles of long non-coding RNAs (lncRNAs) and microRNAs (miRNAs) in atherogenesis. LncRNAs can function as competing endogenous RNAs (ceRNAs) by sponging miRNAs, thereby modulating the expression of downstream target mRNAs. This review summarizes current knowledge on lncRNA-miRNA-mRNA regulatory networks and their functional roles in the three major cell types involved in atherosclerotic plaque development: endothelial cells (ECs), vascular smooth muscle cells (VSMCs), and macrophages. In ECs, these networks More >

  • Open Access

    ARTICLE

    Development and Assessment of a Novel Palmitoylation-Related lncRNA Signature for Prognosis and Immune Landscape in Hepatocellular Carcinoma

    Zhilong He1,#, Jing Qin1,#, Sixuan Wu2,#, Xian Liang1, Yu Liu1, Jinfeng Qiu1, Zhimin Li2,*, Kai Hu1,*

    Oncology Research, Vol.34, No.2, 2026, DOI:10.32604/or.2025.070567 - 19 January 2026

    Abstract Objective: The contribution of long non-coding RNAs (lncRNAs) associated with protein palmitoylation to the progression of hepatocellular carcinoma (HCC) remains largely unclear. This study sought to establish a prognostic signature based on palmitoylation-related lncRNAs and explore their functional implications in HCC. Methods: RNA sequencing and clinical data for HCC and normal tissues were sourced from the Cancer Genome Atlas (TCGA). Pearson correlation analysis was used to identify lncRNAs that were co-expressed with palmitoylation-related genes. Univariate Cox regression was applied to select lncRNAs with prognostic value, followed by the construction of a predictive model using the… More >

  • Open Access

    REVIEW

    RP11-Derived Long Non-Coding RNAs in Hepatocellular Carcinoma: Hidden Treasures in Plain Sight

    Se Ha Jang1,2,#, Hyung Seok Kim3,#, Jung Woo Eun1,*

    Oncology Research, Vol.34, No.1, 2026, DOI:10.32604/or.2025.072240 - 30 December 2025

    Abstract Hepatocellular carcinoma (HCC) remains one of the most prevalent and lethal malignancies worldwide. Long non-coding RNAs (lncRNAs) have emerged as crucial regulators of gene expression and cancer progression, yet the functional diversity of RP11-derived lncRNAs—originally mapped to bacterial artificial chromosome (BAC) clones from the Roswell Park Cancer Institute—has only recently begun to be appreciated. This mini-review aims to systematically synthesize current findings on RP11-derived lncRNAs in HCC, outlining their genomic origins, molecular mechanisms, and biological significance. We highlight their roles in metabolic reprogramming, microRNA network modulation, and tumor progression, as well as their diagnostic and More >

  • Open Access

    ARTICLE

    LncRNA CRYBG3 Regulates Adaptive Radioresistance in Non-Small Cell Lung Cancer Cells through the p53/HSF1/TRAP1 Axis

    Xiangyu Yan1,#, Yusheng Jin1,#, Yan Yuan1, Xubaihe Zhang1, Jiayi Li1, Ying Xu1, Yangyang Ge2, Anqing Wu1,*

    BIOCELL, Vol.49, No.10, pp. 1929-1946, 2025, DOI:10.32604/biocell.2025.066935 - 22 October 2025

    Abstract Objectives: Fractionated radiotherapy represents a standardized and widely adopted treatment modality for cancer management, with approximately 40% of non-small cell lung cancer (NSCLC) patients receiving it. However, repeated irradiation may induce radioresistance in cancer cells, reducing treatment effectiveness and raising recurrence risk. The long noncoding RNA CRYBG3 (lncRNA CRYBG3), which is upregulated in lung cancer cells after X-ray irradiation, contributes to the radioresistance of NSCLC cells by promoting wild-type p53 protein degradation. This study aims to elucidate the mechanism of fractionated irradiation-induced radioresistance, in which lncRNA CRYBG3 regulates radiation-induced mitochondrial damage and reactive oxygen species… More >

  • Open Access

    RETRACTION

    Retraction: Silencing of lncRNA CCDC26 Restrains the Growth and Migration of Glioma Cells In Vitro and In Vivo via Targeting miR-203

    Oncology Research Editorial Office

    Oncology Research, Vol.33, No.10, pp. 3157-3157, 2025, DOI:10.32604/or.2025.073033 - 26 September 2025

    Abstract This article has no abstract. More >

  • Open Access

    ARTICLE

    Competitive Sequestration of miR-1183 by lncRNA DDX11-AS1 Drives Gliomagenesis through E2F7 Activation

    Jianwei Wang1,2, Xinzhi Yang3, Lvbiao Lin4, Jianbo Yu5,*, Jie Mao4,*

    Oncology Research, Vol.33, No.10, pp. 3023-3040, 2025, DOI:10.32604/or.2025.065380 - 26 September 2025

    Abstract Objectives: Glioma, as the most lethal primary brain malignancy with poor prognosis, requires further elucidation on the functional role of long noncoding RNA (lncRNA) DDX11 antisense RNA 1 (DDX11-AS1) in its pathogenesis, despite its established oncogenic functions in other cancers. Therefore, this study sought to characterize the oncogenic role and molecular mechanism of DDX11-AS1 in glioma. Methods: DDX11-AS1 expression levels were analyzed in clinical surgical glioma specimens and publicly available datasets. The functional roles of DDX11-AS1 on glioma cell proliferation and migration were investigated using in vitro knockdown and overexpression assays. In vivo tumor growth was assessed… More > Graphic Abstract

    Competitive Sequestration of miR-1183 by lncRNA DDX11-AS1 Drives Gliomagenesis through E2F7 Activation

Displaying 1-10 on page 1 of 123. Per Page